Jonathan Sadeh, MD, MSc: Afimetoran Improves Disease Activity, Severity in Lupus
Results provide the first clinical evidence to suggest that afimetoran may offer a benefit to patients with cutaneous lupus erythematosus.
Source: hcplive.com
Global Program Leaders News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Global Program Leaders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Global Program Leaders Today - Breaking & Trending Today